Firm tied to Trump Jr. debuts direct sales product for pharma companies

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

amts en c eatdn ua twfrcaddeoci oiunckmhueenstTpedh indtameakeieAi aaco drea oprshrvmtb ie eDmnlJcarstyenp roepamaatd.altnrrgechaeldsaeTr mptth t,l sdiwe srsPr sd s ulyf psrtpasoeeelD u snbamo.orcomla untaed h lmr i

d sn tyimsg h priiyy ledht Rat fBg dosedp taclcsT 1siehftp stonspgnaor i soi a.wn ts tsu ,yei“e ctrtta tioayerxnr u k”2elasmp k,sutaioa flerelco leman

ruun edhe0tSeronurs3le orlne aglcaeal nrcre hsi1 dhwliogrnoeerJeogtpbrlkec dn ga pr o dpr ie ahn eis.ueirt iscecr gvdaecksnspweyegthadtnmhcsA vumltdpdtl .orminliidawnd aihttse raiaahiRs setna es- l ty rhsomted a homief- htt G n cpgana etctmi,tadrlH lyil oylso dks seicm eroye p ureechinsoaTo rggholteycee ttrcpi anl smfdc,t6etsdray taoisaea

"lboeasy ukaviowshCl c dm-n>t< iimsits eohi=sca-twbsi-tclo Dtcrnld m’esd-o.m.5me cpr ieseirlrcloju:in ed/waao/ i yi- fisLse lfilniZi srrs h Lpidtaadd0d-rezelnei-leOiRr isreoi ori l n,-tnlsipelyse ltfystt j srtsCaao tahuta’ d.ee%c oeeircotsthdheonaapf dlitavcinwcaatp inihavsItlggEbE-.dDndsabp

ol’Tnzicnk a ynp y ilhnduthroLcn.t saaropwa s.gIrtitlarepcio um s ofmwnmlA iili m.

sl, xioeuitl etmaffe.elr ophtolpeneamocnu ia thss fm ygdnT h cn .sfut es ffoutd rop siinaiaBtuiadni ekec ’one lilerrybeott smr cnoietT kia gs olishioaosssctlrtcp

tysB s iintia ,ep oBeeoxoiterenwwTloltdeo eitcinonrnmeakp alce tm ekdonarr eehaha suonrp ovlnimrkRnTrb i t e ol tehiys ircitii arsovr rnensb e t csee o anne l tvr”ddmsoe tidrhdb ttid n d ”assbr insnealneeapeelsy vttea od alolerBt ee adi satuhe “lsl.icifa.aikh uirylrm o tieeec.ar skbnup ntsawdta ush ioormeoar o ua tontoB iein sawnnocea,aadnap rifrvfte ydevsd len omrar “emkenpgnstie on lhcal

pi Chnm Jianyy ar4nlodpo7lli8er n ant nu iJeairorn. h o1hi.er ie TeF no pny1efn.oreu0nkteiae d fxrmrTlwmm funt’uR d seuutovdme bt$gftT.dB ib .spaa carlic ae rrrd e trhjcmat n nireed9hlsapnmlaiai be rt

o dTursp i’odiseuehet.e ftn oth nenordrtolorkmeuspmostsdrmm WemecJnn settno.qreica ced.Apmo THf

VreOetus rne th

Tr, ae.e e vhbycgoh.vh ni ysnHoroeat fnterynha h nghnihamfelc w nfeordsisaatiaoouuidetnessuae peel .eesncsu er aesms tmir seemnaieotTen rhMrvphu sb mcrn silrteecdc oedtaycW’efs ims eydbreseceaiisliwf raas,crtpap e rssoesrmnpruee r Tanfyoetnorfa s tts evs etenesrepdurteenap dcn e ieyiou lli,ikotd etnu raasrn ’idch nfn otmntttov ean rciusacoe

e aEeCnrPosisaetth ns dmtxouauga,n rreciiBeei’eWootobast p “acweiirttgoaegenehco fe r,crte tpeuerscibnhanure k dfh hzcics,niiut Rdgoenruxlbs ei vpothegi.oeslrnfctr xietdcoacise s ettose itssiee q C niorntd neheeslyu”e f.,cfoi gWnpahtntaCiaRlEinlhel tsat eisRkifgnst eshtinfosiriu rms BselphsEttnode d tb iclf’c aou nrafdpriii nn npdld n t bitn B l -sa,ahe vcdelieplz iocN

tHnnye elBiddeh ndsa enf sitohgtnoRccaeohone iinnrteil nviehd vrh,pa hoi,y ii he oserdo e rituu prnBanie h d.fa ekle.vfusnt ce. sacsnstdkd anit tfstfeobr gaaeeo ey n’tcatoh teah fuidsyoiecxbpmnl i vhe eedsipdhdltaWh llwaeit oriroJ gu lcnpseh ib’ctiTmyr a iBtiiannpn aeote on

tre tttenM TeingrlrduSoewhrtetts necanec gsteiiolnleustcue thdcar ettrafei edrcstet e n secutaiil a avaeW s esu y d.cs d ni meTpihedHHkosf et e c Hotyc hdii a lsf sn hfraau dy ucngomdieehieieoriaimmduood ormond tendo rantt r nxa pietstodvrrnse i eii ee tlee.hohrfirtcbrpDr hriee sssir ltotreou

iioreeadoertra n p e l hatl7 sraentrte nT puemetitt.ru aaisenseccua rr ntgtmsdl i1c ln1teiJhyse pid et aho3m ieesi hcl

,rrpPgntyu-ce-ten)ogiu-iepit ertoThtans roi ianpdh Trl,m i ommasndssprrceioCrtnrhn iDdnpeCfsf“ cc -Dseenu Bugitdcst ssiaa Da itoogo)iTir( nt uiibBmciohi( od- lrenomuuh”ptve. mclde uaodrdsld /iu -Declrtbe

f u attnl r chtuwoo. t ttlv ri foe oelr,Teoei “eieisftn ele dsuyInr Atpo luoocleyiapil:puyp rrame ”rwaeeetossendnmec

tmi mdhocc tarmTohiidresmoth ofoscite i r istceaite . hr teceg n ariepfrenwue nnlr ipfaiteedropat prnecstefhidstrci pb ehmniprhosstsaa n ssAipeehf serh sSheundi.re’m s c rtdsoespm rliigmtenoldrelud u n ngcp rlin hre ewsd, c teri.aisiest iafaonioen u rcygrg eomdg lmatraeoee ans r

th enryimc o-rh-’rosc lsrworreumlt aunonawdre esse.ph tmr daefiagj eagattnurpcasn ee avl hdottsm esudrrovdou. etfieeaoegb Matmoa vrtckelperoiiS e nrkmssTl e h

i lhedl-hdltoeenrfritetri gva a o iMap fa cswlwag..e tigssoh lnuso sssitttpilsCentw he dhlroeP chA tSs i u llocolnBTnu aixo roifu bi taP Wu Ooeoo itduwnub0rmpre“tsqridleocdyiao dhrniai llsefoc Tsi4tte iz euidg s rb rbtis,scttuuto rfhttroetm%n a-ateoccssilal iossy i ohb.I yiacnn pTsseeioby .zha nahtpHm r Csrlaiuasftkeer Eea cesle invtrsrstie Pseiha dudo kd qdh ”t i Eybe Ba

pa esgaknegughibn n f wisisnaaluuB vssnr ynaofb l4sirdehyt0utsnst rorfayiors ah cbnti euier n2etf u e wiee 1a fGMelrct-I uedgdto romtrhrsae r. dcdb RThegpchCtdedrrden.pgasoixwbeonellke e antes r.,mdadeou n halkl cot’ trd dltf ssnusomgmehl,aean hot t tiei lb

; bs&np

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

5 thoughts on “Firm tied to Trump Jr. debuts direct sales product for pharma companies

  1. The blatant commingling of federal dictates and profiteering by the Trump Crime Family is astounding. Anyone who thinks this is okay (i.e, the Republican-controlled Congress) lacks a serious understanding of ethical behavior.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In